Health & Biotech
Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast.
In this episode, Tim chats with Recce Pharmaceuticals (ASX:RCE) managing director and CEO James Graham.
Cracking the antibiotics code may be the challenge of the century, according to host Tim Boreham. So what has Recce been cooking up and what are its plans with synthetic antibiotics?
On mobile? Click here to listen with Apple podcasts.
Like to tune in through another app? Just search for Health Kick Podcast with Tim Boreham and subscribe!
This podcast was developed in collaboration with Recce Pharmaceuticals, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.
Health & Biotech
Health & Biotech
Health & Biotech
